Abbott Laboratories (ABT) Interest Expenses (2009 - 2026)

Abbott Laboratories has disclosed Interest Expenses across 18 years of filings, most recently posting $174.0 million for Q1 2026.

• Interest Expenses for Q1 2026 came in at $174.0 million, up 32.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $536.0 million (down 2.37% YoY), and the FY2025 annual result was $493.0 million, down 11.81% from the prior year.
• Interest Expenses came in at $174.0 million for Q1 2026 at Abbott Laboratories, up from $120.0 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $174.0 million in Q1 2026 to a low of $120.0 million in Q4 2025.
• The 5-year median for Interest Expenses is $141.0 million (2022), against an average of $142.4 million.
• Across the five-year window, Interest Expenses decreased 14.79% in 2025 and jumped 32.82% in 2026, its largest moves.
• Abbott Laboratories' Interest Expenses stood at $154.0 million in 2022, then advanced by 3.25% to $159.0 million in 2023, then retreated by 14.47% to $136.0 million in 2024, then decreased by 11.76% to $120.0 million in 2025, then surged by 45.0% to $174.0 million in 2026.
• The last three Interest Expenses figures came in at $174.0 million (Q1 2026), $120.0 million (Q4 2025), and $121.0 million (Q3 2025), per Business Quant data.